Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Plixorafenib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FORE Biotherapeutics Presents Plixorafenib Results at AACR 2025
    FORE Biotherapeutics Presents Plixorafenib Results at AACR 2025

    25 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250424007807/en/FORE-Biotherapeutics-Presents-New-Plixorafenib-Results-at-AACR-2025-Demonstrating-Pharmacodynamic-Effect-in-Clinical-Tumor-Biopsies-and-Decreased-V600E-Mutant-Allele-Frequency-in-ctDNA-of-85-of-Patients

    BUSINESSWIRE
    25 Apr 2025
    Share Share
    FORE Bio to Present Plixorafenib Abstracts at AACR Meeting
    FORE Bio to Present Plixorafenib Abstracts at AACR Meeting

    25 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250325183994/en/FORE-Biotherapeutics-to-Present-Two-Plixorafenib-Abstracts-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2025

    BUSINESSWIRE
    25 Mar 2025
    Share Share
    FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data
    FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data

    10 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231110438808/en

    BUSINESSWIRE
    10 Nov 2023
    Share Share
    FORE Biotherapeutics to Present Plixorafenib Nonclinical Data
    FORE Biotherapeutics to Present Plixorafenib Nonclinical Data

    12 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231012328226/en

    BUSINESSWIRE
    12 Oct 2023
    Share Share